Browse All Providers

Find a Provider Near You

Find A Provider
Browse All Specialties

Learn more about a specialty

Find A Specialty
Accepted Insurance

Check to see if your insurance plan is accepted by CU Medicine Clinics.

Check for Insurance

Practice Locations

UCHealth Anschutz Outpatient Pavilion - Anschutz Medical Campus
1635 Aurora Ct Aurora, CO 80045

720-848-0000

Cheryl Meguid, DNP, NP

Schedule Appointment

  • Title(s)

    Director, Pancreatic Cancer High Risk Screening Clinic, Regional Medical Director, Oncology Multidisciplinary Programs, Pancreas & Biliary Cancer Multidisciplinary Clinic Coordinator

  • Gender

    Female

  • Languages

    English

  • Department

    Professor of Clinical Practice, Surgery-Surgical Oncology

  • Primary Clinic Phone

    (720) 848-8096

  • Hospital Affiliations

    University of Colorado Hospital
Print Share

Referring Provider Info

Locations

Practice Locations

UCHealth Anschutz Outpatient Pavilion - Anschutz Medical Campus
1635 Aurora Ct
Aurora, CO 80045

720-848-0000

Get directions

Provider Expertise

Clinical Interest for Patients

I am interested in improving the Multidisciplinary approach to Pancreas & Biliary disease and hope to promote the use of Nurse Practitioners in this setting. I am also working with pancreas specialists to promote early diagnosis and expedited treatment of of Pancreas & Biliary disease. I am also very interested in standardizing surveillance protocols for high risk patients.


Conditions & Treatments

  • Cancers

    Pancreatic Cancer

Education & Training

Undergraduate Schools

BSN, Towson University (MD) (2003)


Graduate Schools

MSN, Johns Hopkins University (2008)

DNP, University of Washington (2012)

MBA, University of Colorado Denver (2023)


Professional Memberships

American Academy of Nurse Practitioners (AANP), Member


American College of Nurse Practitioners (ACNP), Member


information for referring providers

Referral Contact Phone

(720) 848-8096

Clinical Interests for Referring Providers

Pancreas Cancer, Biliary Cancer, Pancreas Cysts (IPMN/MCN). Neuroendocrine tumors, and patients requiring routine surveillance